Clinical perspectives on preclinical models of bone pain: questions and promises
- PMID: 21868166
- DOI: 10.1016/j.pain.2011.08.008
Clinical perspectives on preclinical models of bone pain: questions and promises
Comment on
-
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.Pain. 2011 Nov;152(11):2564-2574. doi: 10.1016/j.pain.2011.07.020. Epub 2011 Sep 9. Pain. 2011. PMID: 21907491 Free PMC article.
References
-
- Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain. 2011;152:S74-S83.
-
- Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP task force on cancer pain. International association for the study of pain. Pain. 1999;82:263-274.
-
- Guise T. Examining the metastatic niche: targeting the microenvironment. Semin Oncol. 2010;37:S2-S14.
-
- Jimenez-Andrade JM, Ghilardi JR, Castañeda-Corral G, Kuskowski MA, Mantyh PW. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain. 2011;152:2564-2574.
-
- Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW. Bone cancer pain. Ann NY Acad Sci. 2010;1198:173-181.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
